Ligand Pharmaceuticals Incorporated
LGND stock score: 65/100
$306.40 · +3.07% · Scored Oct 20, 2026
- Technical
- 71
- Fundamental
- 59
- News
- 60
The reading
Ligand Pharmaceuticals (LGND) scores 65 out of 100, which reads neutral, higher than 94% of Healthcare stocks and 90% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 71, fundamentals 59.
Among the fundamentals, Quick Ratio at 100 and Current Ratio at 100 score highest, while Price to Sales Ratio at 1 weighs the most against it.
On the daily chart, trend-following indicators average 67 and contrarian oscillators 48.
News sentiment is positive at 60; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 61 to 78, and it is down 13 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward LGND’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
59Pulling it up
- Quick Ratio100
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Current Ratio100
Current ratio measures ability to pay short-term liabilities with current assets.
- Fund Ownership100
Fund ownership tracks institutional investor holdings and changes.
Holding it back
- Price to Sales Ratio1
Price-to-Sales ratio compares market capitalization to annual revenue.
- Fair Value2
Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.
- EV/EBITDA3
EV/EBITDA compares the whole company's value, debt included, with its operating earnings before depreciation.
41 weighted scorers.
Technical · daily
66Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- SMA 20 Cross Up100
SMA 20 Cross Up tracks when very short-term averages cross above the 20-period SMA.
- 52-Week Change100
The price change over the last 52 weeks.
Holding it back
- Bollinger Bands (50)14
Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.
- SPY SMA 1026
SPY SMA 10 evaluates the S&P 500 (SPY) position relative to its 10-period simple moving average.
- SMA 200 Cross Up31
SMA 200 Cross Up tracks when faster moving averages cross above the 200-period SMA.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 60
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 55 | 1 |
| Daily | 66 | 3 |
| Weekly | 72 | 2 |
| Monthly | 77 | 2 |
| Quarterly | 78 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 20, 2026 | 65 |
| Oct 19, 2026 | 64 |
| Oct 18, 2026 | 63 |
| Oct 17, 2026 | 63 |
| Oct 16, 2026 | 63 |
| Oct 15, 2026 | 64 |
| Oct 14, 2026 | 63 |
| Oct 13, 2026 | 65 |
| Oct 12, 2026 | 66 |
| Oct 11, 2026 | 65 |
| Oct 10, 2026 | 65 |
| Oct 9, 2026 | 65 |
| Oct 8, 2026 | 63 |
| Oct 7, 2026 | 63 |
| Oct 6, 2026 | 64 |
| Oct 5, 2026 | 65 |
| Oct 4, 2026 | 64 |
| Oct 3, 2026 | 65 |
| Oct 2, 2026 | 65 |
| Oct 1, 2026 | 64 |
| Sep 30, 2026 | 65 |
| Sep 29, 2026 | 65 |
| Sep 28, 2026 | 66 |
| Sep 27, 2026 | 65 |
| Sep 26, 2026 | 66 |
| Sep 25, 2026 | 65 |
| Sep 24, 2026 | 66 |
| Sep 23, 2026 | 66 |
| Sep 22, 2026 | 66 |
| Sep 21, 2026 | 65 |
| Sep 20, 2026 | 63 |
| Sep 19, 2026 | 63 |
| Sep 18, 2026 | 63 |
| Sep 17, 2026 | 63 |
| Sep 16, 2026 | 61 |
| Sep 15, 2026 | 61 |
| Sep 14, 2026 | 61 |
| Sep 13, 2026 | 63 |
| Sep 12, 2026 | 63 |
| Sep 11, 2026 | 62 |
| Sep 10, 2026 | 64 |
| Sep 9, 2026 | 64 |
| Sep 8, 2026 | 65 |
| Sep 7, 2026 | 63 |
| Sep 6, 2026 | 63 |
| Sep 5, 2026 | 63 |
| Sep 4, 2026 | 64 |
| Sep 3, 2026 | 65 |
| Sep 2, 2026 | 64 |
| Sep 1, 2026 | 63 |
| Aug 31, 2026 | 62 |
| Aug 30, 2026 | 61 |
| Aug 29, 2026 | 61 |
| Aug 28, 2026 | 62 |
| Aug 27, 2026 | 61 |
| Aug 26, 2026 | 62 |
| Aug 25, 2026 | 62 |
| Aug 24, 2026 | 61 |
| Aug 23, 2026 | 62 |
| Aug 22, 2026 | 62 |
| Aug 20, 2026 | 63 |
| Aug 19, 2026 | 64 |
| Aug 18, 2026 | 63 |
| Aug 17, 2026 | 64 |
| Aug 16, 2026 | 63 |
| Aug 15, 2026 | 64 |
| Aug 14, 2026 | 63 |
| Aug 13, 2026 | 63 |
| Aug 12, 2026 | 64 |
| Aug 11, 2026 | 62 |
| Aug 10, 2026 | 63 |
| Aug 9, 2026 | 63 |
| Aug 8, 2026 | 63 |
| Aug 7, 2026 | 64 |
| Aug 6, 2026 | 61 |
| Aug 5, 2026 | 61 |
| Aug 3, 2026 | 61 |
| Aug 2, 2026 | 64 |
| Jul 31, 2026 | 66 |
| Jul 30, 2026 | 76 |
| Jul 29, 2026 | 76 |
| Jul 28, 2026 | 77 |
| Jul 27, 2026 | 77 |
| Jul 26, 2026 | 78 |
| Jul 25, 2026 | 78 |
Key facts
- Market cap
- $6.1B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 1.01
- Risk grade (1–10)
- 4
- Next earnings
- Oct 29, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| IOVA Iovance Biotherapeutics | $6.7B | 54 |
| BLTE Belite Bio | $6.2B | 43 |
| RYTM Rhythm Pharmaceuticals | $6.2B | 46 |
| IMVT Immunovant | $5.9B | 39 |
| KOD Kodiak Sciences | $5.8B | 51 |
| MIRM Mirum Pharmaceuticals | $5.5B | 50 |
Questions
What is LGND's stock score today?
LGND scores 65/100 (Neutral) as of Oct 20, 2026: technical 71, fundamental 59, and news sentiment 60, which is shown but not counted. Scores are recomputed every night.
Is LGND a buy?
The score is not a buy or sell recommendation. A 65 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the LGND score calculated?
103 weighted scorers feed it today: 41 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.